TARO-BUDESONIDE

Google image searchProduct monograph

Active ingredient

budesonide, 0.125 MG/ML

DIN: 02494264

Dosage form(s): SUSPENSION

Route(s) of administration: INHALATION

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC

Date: 04-JUN-2021

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03B — OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS (ATC, ATC/DDD)
• R03BA — Glucocorticoids (ATC, ATC/DDD)
• R03BA02 — BUDESONIDE (ATC/DDD)

Reference brand drug: Rhinocort

Pharmaceutical standard: MFR

External Links for Taro-Budesonide

Search on Google

• Taro-Budesonide side effects
• Taro-Budesonide dosage
• budesonide side effects
• budesonide dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-budesonide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.